Company Description
Acceleron (NASDAQ: XLRN) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.
XLRN stock has gained 61.1% over the past year.
This page provides a comprehensive overview of XLRN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Acceleron (XLRN) stock. Over the past 12 months, the stock has gained 61.1%.
Latest News
Acceleron has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, earnings. View all XLRN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
XLRN Company Profile & Sector Positioning
Acceleron (XLRN) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.